Clinical trials
Carcinoma, Transitional Cell trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Changhai Hospital | 5 |
| Abbisko Therapeutics Co, Ltd | 2 |
| Tianjin Medical University Second Hospital | 2 |
| Chinese Academy of Medical Sciences | 1 |
| Chunguang yang (101937) | 1 |
| Creative Biosciences (Guangzhou) Co., Ltd. | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Jun Guo | 1 |
| Lee's Pharmaceutical Limited | 1 |
| Peking University Cancer Hospital & Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 25 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma, Renal Cell | 2 |
| Disease | 2 |
| Hematuria | 2 |
| Ureteral Neoplasms | 2 |
| Chromosome Aberrations | 1 |
| Colorectal Neoplasms | 1 |
| Cystitis | 1 |
| Endometrial Neoplasms | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.